Skip to main navigation Skip to search Skip to main content

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

Malgorzata Banys-Paluchowski, Tanja Fehm, Wolfgang Janni, Bahriye Aktas, Peter A. Fasching, Sabine Kasimir-Bauer, Karin Milde-Langosch, Klaus Pantel, Brigitte Rack, Sabine Riethdorf, Erich Franz Solomayer, Isabell Witzel, Volkmar Müller

Fingerprint

Dive into the research topics of 'Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology